Searched for
PFIZER PROFIT FORECAST
US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...- Why US stock market Dow Jones, S&P 500 and Nasdaq are surging big today: Dow jumps 350 points, Nasdaq jumps 250 points as Intel hits all-time high driving the rallyUS stock market surges today: why Dow Jones, S&P 500, and Nasdaq are rallying sharply despite global tensions? The Dow Jones Industrial Ave...
- Why is PFE stock falling today despite beating Pfizer's earnings estimates? Key factors investors are watchingPFE stock today: Pfizer's stock dipped despite strong fourth-quarter earnings. Investors reacted to the company's modest 2026 outlook. Decl...
- Pfizer, Novo Nordisk escalate bidding war for obesity drug developer MetseraA fierce bidding war is underway for Metsera, an obesity drug developer. Novo Nordisk has made a $10 billion offer, which Metsera considers...
- Pfizer stock soars as earnings smash expectations, and company raises outlookPFE stock: Pfizer's stock surged following a report of stronger-than-expected earnings, driven by robust sales of COVID-19 products and key...
- Pfizer exceeds Q4 earnings estimates as covid product sales outperform expectationsStrong Covid product sales and cost-cutting initiatives drove Pfizer's $17.76 billion in revenue in Q4, exceeding Wall Street's projections...
- Pfizer Q1 Results: Co lifts profit view on cost cuts, smaller drop in PaxlovidPfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, boosted by cost cu...
- Pfizer shares sink after it resets 2024 Covid expectationsRevenue from Pfizer's COVID-19 vaccine and treatment, which peaked at $57 billion in 2022, are now expected to be $8 billion in 2024, a fur...
- Pfizer Q2 Results: Profit tumbles 77% to $2.3 billion; co trims 2023 revenue outlookThese include US approval for a drug combination for prostate cancer and a needed recommendation on the Abrysvo vaccine from the US Centers...
- Amid Covid vaccine success, BioNTech plans to return €2bn to shareholdersAfter the success of the covid vaccine, BioNTech is planning to return €2bn to shareholders. BioNTech will continue the clinical trial to b...
- Pfizer raises COVID-19 vaccine sales forecast to $36 bn for 2021Driven by an unprecedented vaccination drive against the COVID-19 pandemic globally, Pfizer's shot has quickly become one of the best-selli...
- Johnson & Johnson forecasts $2.5 bn in Covid-19 vaccine sales this yearJ&J said it expects full-year sales of $91.3 billion-$92.1 billion this year from the rest of the business, and $93.8 billion to $94.6 bill...
- Pfizer sees $15 billion in 2021 sales from COVID-19 vaccinePfizer said it had supplied 65 million doses globally and 29 million doses in the United States as of Jan. 31. It expects to supply 200 mil...
- American CEOs most bearish on earnings since 2008 crisisAnalysts now expect per-share earnings from S&P 500 companies to decline 2.1% in the first quarter and fall 1.1% over the following period.
- Pfizer 4Q profit beats views as revenue up 6 pcPfizer Inc.'s new CEO on Tuesday outlined plans to reduce the company's spending and work force and focus more sharply on promising drugs a...
- Pfizer 3Q profit down 70 pc due to chargesPfizer Inc said on Tuesday that revenue in the third quarter jumped 39 per cent, but hefty charges related to that $68 billion purchase dra...
- Pfizer profit dips 2 percent, sales fall much morePfizer Inc posted a 2 percent drop in first-quarter profit Tuesday, as cost-cutting by the world's largest drugmaker couldn't offset big dr...
- Pfizer’s Q3 profit up on downsizing, higher salesPfizer, the world’s biggest drugmaker, said profit tripled because of higher sales of the pain pill Lyrica and lower costs from the 11,000 ...
- J&J profits rise 9 per centHealth care products maker Johnson & Johnson on Tuesday posted a 9 percent increase in its second-quarter profit
- Earnings of consumer cos may be critical for US stocksConsumer-oriented companies are early leaders among US stocks this year. Earnings reports that start pouring in from Wednesday are likely t...
Load More
